Abstract : Breast cancer is the most common cancer among women in both developed and developing countries. Progress in the management of breast cancer in the recent years lead to increase the cost of management. Cancer imposes a substantial economic burden on society. To minimize economic burden of breast cancer. A cross sectional study was conducted in Baghdad including 300 women. Direct face to face interview was used to collect necessary data about disease stage and treatments. The disease was classified into early and late. The cost was in Iraqi dinars. Mean early lab cost was 530450 ±743010.9, therapeutic cost 1398333.3 ±612353, hospitalization cost 1664333.3 ±705113, and diagnostic cost was 698166.7 ±294381. Mean late lab cost was 525250 ±743191.3, therapeutic cost 6005666.7 ±3091808.88, hospitalization cost 3347050 ±1407216.6, and diagnostic cost was 635666.7 ±605956.7. Late costs were much higher than early-stage disease costs. The cost of management of breast cancer is increasing with stage at diagnosis. Screening program is the best way to lower the cost.